When.com Web Search

  1. Ads

    related to: facial expression in parkinson's disease life expectancy

Search results

  1. Results From The WOW.Com Content Network
  2. Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Parkinson's_disease

    Consequently, as global life expectancy has increased, Parkinson's disease prevalence has also risen, with an estimated increase in cases by 74% from 1990 to 2016. [221] The total number is predicted to rise to over 12 million patients by 2040. [222] Some label this a pandemic. [221]

  3. Signs and symptoms of Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Signs_and_symptoms_of...

    Parkinson's Disease causes constipation and gastric dysmotility that is severe enough to endanger comfort and even health. [26] A factor in this is the appearance of Lewy bodies and Lewy neurites even before these affect the functioning of the substantia nigra in the neurons in the enteric nervous system that control gut functions. [27]

  4. Huntington's disease - Wikipedia

    en.wikipedia.org/wiki/Huntington's_disease

    The remaining variation is due to environmental factors and other genes that influence the mechanism of the disease. [26] Life expectancy in HD is generally around 10 to 30 years following the onset of visible symptoms. [26] Juvenile Huntington's disease has a life expectancy rate of 10 years after onset of visible symptoms.

  5. Hypomimia - Wikipedia

    en.wikipedia.org/wiki/Hypomimia

    Hypomimia (masked faces, masking of faces, mask-like facial expression), a medical sign, is a reduced degree of facial expression. It can be caused by motor impairment (for example, weakness or paralysis of the facial muscles), as in Parkinson's disease, or by other causes, such as psychological or psychiatric factors (for example, if a patient ...

  6. Unified Parkinson's disease rating scale - Wikipedia

    en.wikipedia.org/wiki/Unified_Parkinson's_disease...

    The unified Parkinson's disease rating scale (UPDRS) is used to follow the longitudinal course of Parkinson's disease. The UPD rating scale is the most commonly used scale in the clinical study of Parkinson's disease. [1] The UPDRS is made up of these sections: [2] Part I: evaluation of mentation, behavior, and mood

  7. Multiple system atrophy - Wikipedia

    en.wikipedia.org/wiki/Multiple_system_atrophy

    Multiple system atrophy. Multiple system atrophy (MSA) is a rare neurodegenerative disorder [ 1 ] characterized by tremors, slow movement, muscle rigidity, postural instability (collectively known as parkinsonism), autonomic dysfunction and ataxia. This is caused by progressive degeneration of neurons in several parts of the brain including the ...